The short version
13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “requirements related to complying with good manufacturing practices”.
Market view
27 marketed package NDCs · 13 active manufacturers
Most dispensed: 10 mg/mL · Solution/ Drops · #1 bottle/carton / 5 ml in 1 bottle · 10 mg/mL · Solution/ Drops · #1 bottle/carton / 2 ml in 1 bottle · 10 mg/mL · Solution/ Drops · #1 bottle/carton / 15 ml in 1 bottle · 10 mg/mL · Solution/ Drops · #1 bottle, dropper/carton / 5 ml in 1 bottle, dropper
13 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “requirements related to complying with good manufacturing practices”.
Every detected change for atropine sulfate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Cholinergic Muscarinic Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.